TY - JOUR
T1 - Serum albumin is a strong predictor of sepsis outcome in elderly patients
AU - Arnau-Barrés, Isabel
AU - Güerri-Fernández, Robert
AU - Luque, Sonia
AU - Sorli, Luisa
AU - Vázquez, Olga
AU - Miralles, Ramón
PY - 2019/4/4
Y1 - 2019/4/4
N2 - The incidence of sepsis is disproportionately higher in elderly adults, and age is an independent predictor of mortality. Retrospective analysis was conducted among patients admitted to the emergency department in a tertiary teaching hospital from January 2016 to June 2017. To study the prognosis determinants of sepsis among elderly patients attended in the emergency room of a tertiary care hospital. As secondary objectives, we aimed to describe the causes of sepsis, the general outcome, and the general characteristics of these patients. Two hundred thirty-five episodes data of patients admitted throughout the 15-month study period who were diagnosed with sepsis, severe sepsis or septic shock, were included. Throughout the study cohort, 51 patients (21.7%) fulfilled the criteria of severe sepsis or septic shock. All-cause mortality was 11 patients (4.7%) on day 14 and 27 (11.5%) on day 30. Prognosis factors associated with 30-day mortality were the following: albumin level < 2.6 g/dl (first quartile of the overall population), odds ratio (OR 3.26, 95% CI 12–9.41; p = 0.029), Charlson comorbidity index (OR 1.23, 95% CI 1.04–1.45; p = 0.012), C-reactive protein on admission (OR 1.04, 95% CI 0.99–1.08; p = 0.062), and non-adequacy of the initial antimicrobial therapy (OR 3.3, 95% CI 1.06–10.4; p = 0.039). Among elderly patients with sepsis, strong predictors of mortality such as albumin could be considered as part of prognosis and future potential interventions. Adequacy of antimicrobial therapy at admission must be one of the objectives in the treatment of sepsis, also in the elderly, since it is an independent predictor of mortality.
AB - The incidence of sepsis is disproportionately higher in elderly adults, and age is an independent predictor of mortality. Retrospective analysis was conducted among patients admitted to the emergency department in a tertiary teaching hospital from January 2016 to June 2017. To study the prognosis determinants of sepsis among elderly patients attended in the emergency room of a tertiary care hospital. As secondary objectives, we aimed to describe the causes of sepsis, the general outcome, and the general characteristics of these patients. Two hundred thirty-five episodes data of patients admitted throughout the 15-month study period who were diagnosed with sepsis, severe sepsis or septic shock, were included. Throughout the study cohort, 51 patients (21.7%) fulfilled the criteria of severe sepsis or septic shock. All-cause mortality was 11 patients (4.7%) on day 14 and 27 (11.5%) on day 30. Prognosis factors associated with 30-day mortality were the following: albumin level < 2.6 g/dl (first quartile of the overall population), odds ratio (OR 3.26, 95% CI 12–9.41; p = 0.029), Charlson comorbidity index (OR 1.23, 95% CI 1.04–1.45; p = 0.012), C-reactive protein on admission (OR 1.04, 95% CI 0.99–1.08; p = 0.062), and non-adequacy of the initial antimicrobial therapy (OR 3.3, 95% CI 1.06–10.4; p = 0.039). Among elderly patients with sepsis, strong predictors of mortality such as albumin could be considered as part of prognosis and future potential interventions. Adequacy of antimicrobial therapy at admission must be one of the objectives in the treatment of sepsis, also in the elderly, since it is an independent predictor of mortality.
KW - Albumin
KW - Elderly
KW - Mortality
KW - Sepsis
KW - Prognosis
KW - Age Factors
KW - Hospital Mortality
KW - Humans
KW - Risk Factors
KW - Male
KW - Hospitalization
KW - Serum Albumin, Human/analysis
KW - Sepsis/mortality
KW - Hospitals, Teaching
KW - Aged, 80 and over
KW - Female
KW - Aged
KW - Retrospective Studies
KW - Odds Ratio
KW - Emergency Service, Hospital/statistics & numerical data
UR - http://www.mendeley.com/research/serum-albumin-strong-predictor-sepsis-outcome-elderly-patients
UR - https://www.scopus.com/pages/publications/85060573300
U2 - 10.1007/s10096-019-03478-2
DO - 10.1007/s10096-019-03478-2
M3 - Article
C2 - 30680575
SN - 0934-9723
VL - 38
SP - 743
EP - 746
JO - European Journal of Clinical Microbiology and Infectious Diseases
JF - European Journal of Clinical Microbiology and Infectious Diseases
ER -